Authors
Latest:
Investing Tips in a Time of CrisisAmidst this world of unknowns, the authors share some tips and advice to weather the financial fallout of this storm.
Latest:
Boosting Brain Health After COVID-19: A Convergence SolutionHow can we face the current pandemic while addressing the brain health crisis?
Latest:
Exploring the Antisuicidal Effects of LithiumA systematic review and meta-analysis showed moderate-quality evidence supporting lithium’s ability to lower mortality rates.
Latest:
What's Wrong With Health Care in the United States?There are 4 crucial failings in our current health care system, where the importance of relationships is ignored.
Latest:
Psychiatrists’ Response to Human Trafficking: An UpdateHow to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
Latest:
Concurrent Treatment of Eating Disorders and PTSD Leads to Long-Term RecoveryConcurrent treatments targeting eating disorders and PTSD are needed to help these patients with complex conditions.
Latest:
New-Onset Racism or Psychosis?Racism is not usually considered a psychotic symptom and therefore it is not often considered in the diagnosis of schizophrenia.
Latest:
Answering 3 Clinical Questions in the Wake of the Removal of the Clozapine REMS RequirementWithout the scaffolding of the REMS requirement for clozapine, how can you best utilize this treatment?
Latest:
The Isolation and Disconnection of SeniorsSocial distancing and quarantine have been absolutely necessary, but what effect have they had on seniors?
Latest:
Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of DementiaIn this CME article, learn more about the efficacy and tolerability of brexpiprazole for the treatment of agitation among individuals with Alzheimer disease dementia.
Latest:
Validation of Minoritized Experiences: It’s What’s Been MissingInterventions that rely solely on change lack balance. This is especially true when working with minoritized individuals who have very real and justified pain stemming from systemic problems.
Latest:
In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network FunctionThe prevalence of tobacco use in schizophrenia is over 60%—3 times that of the general population. However, the reason for the high prevalence of tobacco use in schizophrenia remains largely unknown.
Latest:
An Open Letter to the Women Who Helped Shape My CareerHow can the women around us help us dream, grow, and serve?
Latest:
Mental Health as a Role in Mortality Rates in Peri- and Postpartum Black WomenBlack mothers in the US experience far worse outcomes. Here’s what clinicians need to know.
Latest:
After the Wildfires: Reflections on Positive Psychiatry and Posttraumatic GrowthHow do psychiatrists and mental health professionals respond when faced with disaster? One psychiatrist shares his story.
Latest:
Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of DementiaIn this CME article, learn more about the efficacy and tolerability of brexpiprazole for the treatment of agitation among individuals with Alzheimer disease dementia.
Latest:
How Can Digital Tools Improve Medication Adherence?Patients’ reports of medication adherence are sometimes inaccurate, but digital tools offer opportunities to collect objective data.
Latest:
Goodbye Noncompetes: Federal Trade Commission Votes to Ban Noncompete ClausesThe Federal Trade Commission voted 3-2 to ban noncompete clauses between employers and workers, citing health care specifically among their reasons for supporting the ban.
Latest:
SPIRIT (Social Psychiatry Interested in Recovery from International Trauma) Voices Some Current ConcernsAll these events that occurred over the weekend bear social psychiatric weight.
Latest:
What Matters Most in Psychedelic-Assisted Psychotherapy?Psychedelics may catalyze rapid improvements in mental health, but they do so firmly rooted in what we already know about the efficacy of psychotherapy.
Latest:
The Role of Orexin Receptor 2 Agonists in Sleep and Narcolepsy Type 1Elena Koundourakis, the head of the Orexin Franchise Development and Portfolio Strategy at Takeda, shares her thoughts on the recent positive topline results from a phase 2 trial evaluating TAK-861, an oral orexin receptor 2 agonist, in patients with narcolepsy type 1.
Latest:
Patient Case: Trauma and Impact of PTSD on Quality of LifeA patient discusses their struggles coming to terms with a posttraumatic stress disorder (PTSD) diagnosis after multiple traumatic events, detailing their initial resistance to seeking help, the breakthrough moments in therapy that led to acceptance, and their ongoing journey of healing through various treatment approaches.
Latest:
Ending the Psychotherapy Civil WarThere is absolutely no good reason for competition among therapies—none is by itself necessary or sufficient, and most are completely complementary, even synergistic.
Latest:
Addressing Burnout in NPs: The Need for Peer Networking, Professional Development, and SupportHow can we help to reduce the risk of burnout among nurse practitioners in psychiatry?
Latest:
The Whole Continuum of Behavioral Health Care: Reintroduction of the 988 Implementation ActThe 988 Implementation Act was introduced on July 25. What impact will it have on care?
Latest:
Advice for Clinicians Treating SchizophreniaSanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP provide some advice to clinicians on explaining schizophrenia to patients and caregivers to achieve understanding and therapy adherence.
Latest:
Media & Mental Health: The Need for More Credible InformationHas the media’s obsession with the COVID-19 pandemic put global mental health at risk?
Latest:
Copilot and Me and AddictionA retired psychiatrist has a conversation with AI about substance use disorder treatment.
Latest:
Interest Grows in Treatment of Mood Disorders by Classic PsychedelicsClassic psychedelic research is rapidly expanding...
